BTL在创纪录的第一季度实现了70%的增长，完成了超过一百万次EMFACE治疗，并推出了首个逆转眼下衰老的非侵入性治疗-动脉网

BTL Surpasses One Million EMFACE Treatments with 70% Growth in Record Q1, Launches First Non-invasive Treatment to Reverse Under-Eye Aging

CISION 等信源发布 2025-04-08 21:00



可切换为仅中文







MARLBOROUGH, Mass.

马尔伯勒，马萨诸塞州

，

April 8, 2025

2025年4月8日

/PRNewswire/ -- BTL, a global leader in medical and aesthetic innovation, announces the launch of EMFACE® Eye, the first non-invasive procedure designed to reverse under-eye aging by restoring muscle tone and soft tissue support at its foundation.

/PRNewswire/ -- 全球医疗和美学创新领域的领导者BTL宣布推出EMFACE® Eye，这是首个旨在通过恢复眼周肌肉张力和软组织支撑来逆转眼部衰老的非侵入性疗程。

This launch comes as EMFACE surpasses one million treatments globally, making it the fastest-growing facial aesthetic technology to date. It follows a record-breaking Q1 2025, with 70% sales growth in

此次发布之际，EMFACE已在全球范围内突破了一百万次治疗，成为迄今为止增长最快的面部美学技术。此前，EMFACE在2025年第一季度创下了销售记录，销售额增长了70%。

North America

北美

, underscoring the momentum behind the brand and its cutting-edge portfolio.

，突显了该品牌及其前沿产品组合背后的强劲势头。

'The response to EMFACE has been phenomenal,'

“EMFACE的反响非常惊人，”

said

说

David Chmel

大卫·赫梅尔

, CEO of BTL Industries.

，BTL工业公司的首席执行官。

'Reaching the one million treatment mark and reporting our strongest Q1 in history is a testament to the power of BTL innovation - and the trust our providers place in us. With EMFACE Eye, we're once again pushing the boundaries of what's possible in non-invasive aesthetics.'

“达到一百万疗程的里程碑，并报告我们历史上最强劲的第一季度，这证明了BTL创新的力量——以及我们的供应商对我们的信任。通过EMFACE Eye，我们再次突破了非侵入性美学的可能界限。”

EMFACE Eye addresses one of the most delicate, and previously hard-to-treat, areas: under-eye region. While traditional approaches have often relied on injectables or surgery to reduce puffiness, dark circles, and hollowness, EMFACE Eye offers a breakthrough complement. It tones the lower orbicularis oculi muscle, lifts soft tissue, and enhances periorbital support..

EMFACE Eye针对的是最娇嫩且以往较难处理的区域之一：眼下区域。传统方法通常依赖注射或手术来减轻浮肿、黑眼圈和凹陷，而EMFACE Eye提供了一种突破性的补充方案。它能够紧致下眼轮匝肌，提升软组织，并增强眶周支撑。

In a quick 20-minute, needle-free procedure, patients experience an average reduction of 1.4mL in eye bag volume, a 28% reduction in crow's feet, and a 64% decrease in dark circles. These clinically backed results require no downtime, making it a breakthrough for both providers and patients alike.

在快速的20分钟无针疗程中，患者平均眼袋体积减少1.4毫升，鱼尾纹减少28%，黑眼圈减少64%。这些经过临床验证的结果无需恢复时间，对医生和患者来说都是一个突破。

Dr.

博士

Melanie Palm

梅拉妮·帕尔姆

, M.D., MBA, a respected cosmetic dermatologist in

，医学博士，工商管理硕士，一位受人尊敬的美容皮肤科医生在

Solana

Beach, CA, praised the advancement:

加利福尼亚州海滩市赞扬了这一进展：

'As a cosmetic dermatologist with a sizeable injectable practice, this is exactly what I've been waiting for. The results include noticeable brightening of the under-eye and buttressing of the infraorbital fat pad, significantly reducing fat pseudo-herniation.'

“作为一名拥有大量注射实践的美容皮肤科医生，这正是我一直在等待的。结果包括眼下明显提亮，并且眶下脂肪垫得到支撑，显著减少了脂肪假性疝出。”

'Emface restores structure and function to the facial anatomy in the most natural way, so we can count on superior results that drive high patient satisfaction.'

“Emface以最自然的方式恢复面部解剖结构和功能，因此我们可以期待卓越的效果，带来高度的患者满意度。”

With the addition of Eye applicators, the EMFACE platform now enables full-face balancing across all anatomical thirds—from forehead lifting to jawline sculpting to under-eye enhancement. The platform supports a comprehensive, layered approach that pairs seamlessly with injectable treatments to deliver natural, harmonious result. .

随着眼部应用器的加入，EMFACE平台现在能够实现全脸在所有解剖学三分之一区域的平衡——从额头提升到下颌线雕塑，再到眼下增强。该平台支持一种全面的、分层的方法，与注射治疗无缝结合，提供自然、和谐的效果。

About BTL

关于BTL

Founded in 1993, BTL is a global leader in medical devices, providing innovative solutions in dermatology, plastic surgery, med spas, orthopedics, joint and spine care, rehabilitation, dentistry, primary care, OB/GYN, and more. With 200+ patents and over 500 in-house engineers, BTL leverages technology and science to advance medical treatments.

BTL成立于1993年，是全球医疗设备领域的领导者，为皮肤科、整形外科、医美 spa、骨科、关节和脊柱护理、康复、牙科、初级保健、妇产科等领域提供创新解决方案。拥有200多项专利和500多名内部工程师，BTL利用技术和科学推动医疗治疗的进步。

Its product portfolio includes , EMSCULPT NEO®, EMFACE®, EXION™, EXOMIND™, EMSELLA®, and others..

其产品组合包括 EMSCULPT NEO®、EMFACE®、EXION™、EXOMIND™、EMSELLA® 等等。

For more information, visit

欲了解更多信息，请访问

www.bodybybtl.com

。

Media Contact

媒体联系人

–

samantha@samanthaslaven.com

萨曼莎@samanthaslaven.com